Price Target of $75
https://www.benzinga.com/news/21/02/19722227/needham-initiates-coverage-on-rocket-pharmaceuticals-with-buy-rating-announces-price-target-of-75
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.